285 related articles for article (PubMed ID: 10792847)
1. Binding of murine antibodies against whole-cell pertussis vaccine or filamentous haemagglutinin by Bordetella pertussis from patients with whooping cough.
van den Berg BM; Beekhuizen H; Van Furth R; Mooi FR
Scand J Immunol; 2000 May; 51(5):530-2. PubMed ID: 10792847
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF
Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
[TBL] [Abstract][Full Text] [Related]
3. Serological correlates in whooping cough.
Granström M; Granström G
Vaccine; 1993; 11(4):445-8. PubMed ID: 8470429
[TBL] [Abstract][Full Text] [Related]
4. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
Cahill ES; O'Hagan DT; Illum L; Redhead K
FEMS Microbiol Lett; 1993 Mar; 107(2-3):211-6. PubMed ID: 8472903
[TBL] [Abstract][Full Text] [Related]
5. Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017.
Xu Z; Octavia S; Luu LDW; Payne M; Timms V; Tay CY; Keil AD; Sintchenko V; Guiso N; Lan R
Emerg Infect Dis; 2019 Jun; 25(6):1196-1199. PubMed ID: 31107218
[TBL] [Abstract][Full Text] [Related]
6. The cellular immune response to Bordetella pertussis in two children with whooping cough.
Hafler JP; Pohl-Koppe A
Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
[TBL] [Abstract][Full Text] [Related]
7. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children.
Ashworth LA; Robinson A; Irons LI; Morgan CP; Isaacs D
Lancet; 1983 Oct; 2(8355):878-81. PubMed ID: 6137697
[TBL] [Abstract][Full Text] [Related]
8. Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France.
Grimprel E; Bégué P; Anjak I; Njamkepo E; François P; Guiso N
Clin Diagn Lab Immunol; 1996 Jan; 3(1):93-7. PubMed ID: 8770511
[TBL] [Abstract][Full Text] [Related]
9. Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin.
Leininger E; Bowen S; Renauld-Mongénie G; Rouse JH; Menozzi FD; Locht C; Heron I; Brennan MJ
J Infect Dis; 1997 Jun; 175(6):1423-31. PubMed ID: 9180182
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of in vivo-expressed autotransporters against Bordetella pertussis infection.
Suzuki K; Shinzawa N; Ishigaki K; Nakamura K; Abe H; Fukui-Miyazaki A; Ikuta K; Horiguchi Y
Microbiol Immunol; 2017 Sep; 61(9):371-379. PubMed ID: 28752940
[TBL] [Abstract][Full Text] [Related]
11. Eighty-kilodalton N-terminal moiety of Bordetella pertussis filamentous hemagglutinin: adherence, immunogenicity, and protective role.
Alonso S; Reveneau N; Pethe K; Locht C
Infect Immun; 2002 Aug; 70(8):4142-7. PubMed ID: 12117922
[TBL] [Abstract][Full Text] [Related]
12. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years.
Cattaneo LA; Reed GW; Haase DH; Wills MJ; Edwards KM
J Infect Dis; 1996 May; 173(5):1256-9. PubMed ID: 8627081
[TBL] [Abstract][Full Text] [Related]
13. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.
Storsaeter J; Hallander HO; Gustafsson L; Olin P
Vaccine; 1998 Dec; 16(20):1907-16. PubMed ID: 9796042
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children.
Podda A; Carapella De Luca E; Titone L; Casadei AM; Cascio A; Bartalini M; Volpini G; Peppoloni S; Marsili I; Nencioni L
J Pediatr; 1993 Jul; 123(1):81-4. PubMed ID: 8320630
[TBL] [Abstract][Full Text] [Related]
15. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
[TBL] [Abstract][Full Text] [Related]
16. Serum IgG antibody response to pertussis toxin in persons for whom pertussis vaccination failed depends upon the number of antigens in the vaccine.
Cherry JD
Clin Infect Dis; 1999 Mar; 28(3):560-1. PubMed ID: 10194078
[No Abstract] [Full Text] [Related]
17. History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin.
Zackrisson G; Taranger J; Trollfors B
J Pediatr; 1990 Feb; 116(2):190-4. PubMed ID: 2299488
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to filamentous hemagglutinin of Bordetella pertussis and protection against whooping cough in schoolchildren.
He Q; Viljanen MK; Olander RM; Bogaerts H; De Grave D; Ruuskanen O; Mertsola J
J Infect Dis; 1994 Sep; 170(3):705-8. PubMed ID: 8077734
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
Watanabe M; Nagai M
Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
[TBL] [Abstract][Full Text] [Related]
20. Antigenic analysis of Bordetella pertussis filamentous hemagglutinin with phage display libraries and rabbit anti-filamentous hemagglutinin polyclonal antibodies.
Wilson DR; Siebers A; Finlay BB
Infect Immun; 1998 Oct; 66(10):4884-94. PubMed ID: 9746593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]